LFST vs. PRVA, AMEH, PINC, MGLN, PGNY, USPH, PNTG, INNV, WGS, and TALK
Should you be buying LifeStance Health Group stock or one of its competitors? The main competitors of LifeStance Health Group include Privia Health Group (PRVA), Apollo Medical (AMEH), Premier (PINC), Magellan Health (MGLN), Progyny (PGNY), U.S. Physical Therapy (USPH), The Pennant Group (PNTG), InnovAge (INNV), GeneDx (WGS), and Talkspace (TALK). These companies are all part of the "medical" sector.
LifeStance Health Group (NASDAQ:LFST) and Privia Health Group (NASDAQ:PRVA) are both mid-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, community ranking, earnings, dividends, profitability, analyst recommendations, valuation and risk.
In the previous week, Privia Health Group had 11 more articles in the media than LifeStance Health Group. MarketBeat recorded 16 mentions for Privia Health Group and 5 mentions for LifeStance Health Group. Privia Health Group's average media sentiment score of 0.95 beat LifeStance Health Group's score of 0.55 indicating that Privia Health Group is being referred to more favorably in the news media.
Privia Health Group received 47 more outperform votes than LifeStance Health Group when rated by MarketBeat users. Likewise, 73.08% of users gave Privia Health Group an outperform vote while only 26.32% of users gave LifeStance Health Group an outperform vote.
85.5% of LifeStance Health Group shares are owned by institutional investors. Comparatively, 94.5% of Privia Health Group shares are owned by institutional investors. 6.6% of LifeStance Health Group shares are owned by company insiders. Comparatively, 14.2% of Privia Health Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
LifeStance Health Group presently has a consensus price target of $8.80, suggesting a potential upside of 57.99%. Privia Health Group has a consensus price target of $24.92, suggesting a potential upside of 43.48%. Given LifeStance Health Group's higher possible upside, equities research analysts plainly believe LifeStance Health Group is more favorable than Privia Health Group.
LifeStance Health Group has a beta of 1.29, suggesting that its stock price is 29% more volatile than the S&P 500. Comparatively, Privia Health Group has a beta of 0.81, suggesting that its stock price is 19% less volatile than the S&P 500.
Privia Health Group has a net margin of 1.11% compared to LifeStance Health Group's net margin of -15.69%. Privia Health Group's return on equity of 3.13% beat LifeStance Health Group's return on equity.
Privia Health Group has higher revenue and earnings than LifeStance Health Group. LifeStance Health Group is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.
Summary
Privia Health Group beats LifeStance Health Group on 16 of the 19 factors compared between the two stocks.
Get LifeStance Health Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for LFST and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding LFST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
LifeStance Health Group Competitors List
Related Companies and Tools
